Excluding CYP1A1, FRMD4A and GF1 CpGs did not affect the association of Score-15 and Score-19 with lung cancer risk, and only the FRMD4A CpG score was associated with lung cancer risk (Table 5). The gene discussed is CYP1A1; the disease is lung cancer.